376 medicines can't be sold in a batch of hospitals

A large number of varieties need to be removed from the network

On April 25, the Henan Provincial Public Resources Trading Center issued the "Notice on Publicizing the Evaluation Results of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Non-selected Drugs" (hereinafter referred to as the "Notice").

According to the "Notice", 376 drugs were removed from the Internet.

It is worth noting that ambroxol, gliclazide, loratadine, semitoprazole and other varieties with a large number of approvals, a large number of drugs with different specifications have been cancelled and listed under the same generic name, involving many well-known Pharmaceutical companies.

1.

According to the "Notice on Carrying out the Second Batch of State-Organized Drug Centralized Procurement of Non-selected Drug Price Declaration Work" issued by the Henan Provincial Medical Insurance Bureau on April 18.

Based on the above requirements, in the drug application, there are 3 or more manufacturers that have passed the consistency evaluation of the generic name of the same type of drug, and they will be removed from the Internet if they have not passed the evaluation.

2.

On January 7, the Inner Mongolia Autonomous Region Drug Device Centralized Procurement Service Center issued the "Notice of Inner Mongolia Autonomous Region on Announcement of the Price Adjustment Results of Unselected Drugs in the Centralized Procurement of Drugs Organized by the State".

On March 10, the Shandong Provincial Public Resources Trading Center issued the "Notice of Shandong Provincial Public Resources Trading Center on Publicizing the Price Adjustment of the Third Batch of Unselected Drugs for Centralized Procurement of National Organizations", which gave an over-comment on the "multi-package products that do not match the price difference".

On April 16, the Hainan Provincial Public Resources Trading Service Center issued the "Notice of Hainan Province on Adjusting the Online Prices of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Unselected Drugs", in accordance with the "National Online Lowest Price, and is not higher than the Shanghai No.

Up to now, the fourth batch of centralized procurement organized by the state involves 158 varieties to be selected.

3.

On April 16, the Henan Provincial Public Resources Trading Center issued the "Notice of Henan Province on Matters Concerning Declaring the Price of the Fourth Batch of National-Organized Drug Centralized Procurement of Non-selected Drugs" to adjust the price of the fourth batch of national centralized procurement of non-selected drugs.

According to Cyber ​​Blue, a total of 337 medicines were evaluated for price this time.

According to the "National Organizational Centralized Procurement of Unselected Drug Price Adjustment Program" issued by Shandong Province last year: The price of generic drugs that have passed the national drug quality and efficacy consistency evaluation among the unselected drugs cannot exceed the online price of the original research drug after the price adjustment; The online price of other generic drugs that have passed the consistency evaluation of drug quality and efficacy shall not be higher than the online price of the selected product; among the unselected products, products of the same type (same dosage form, same specification) and different packaging products of the same enterprise must comply with the price difference rules.

On April 6, the Anhui Provincial Pharmaceutical Centralized Procurement Platform also issued a notice, according to the "Notice of the General Office of the State Council on Printing and Distributing the Nationally Organized Pharmaceutical Centralized Procurement and Use Pilot Program", etc.
, to carry out the third batch of national drug centralized procurement (Anhui) related drug linkages Price cut work.

At present, the fifth batch of national-organized drug procurement has also started, which will have a greater impact on the company's over-evaluation application policy and market structure in the future, and more drugs may face price reductions.

Attachment: List of the fourth batch of non-selected drugs for the centralized procurement of drugs organized by the state to cancel the eligibility list

Attachment: The fourth batch of nationally organized drug centralized procurement of non-selected drugs price evaluation table